Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 1,384.20 -11.40  | -0.82% -16.76% 52.12 23,466.97
NSE Price: Sep 20, 15:55 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 20, 15:55 1,384.20 -11.40 -0.82% 1,381.00 1,395.60 141,731 1,366.80 - 1,423.00
BSE Sep 20, 2019 1,385.25 -11.15 -0.80% 1,390.00 1,396.40 10,949 1,371.00 - 1,425.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 32,127 P/B: 10.40 NSE Code: GLAXO
52-Week Range: R 1,130.00 - 1,694.00 Dividend Yield: 1.44% BSE Code: 500660
TTM EPS: R 26.58 Book Value: R 133.16 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma -8.65 14.66 10.76 -16.72 -0.72 2.05 6.46
S&P BSE Mid Cap -8.54 5.08 -3.81 -11.01 2.48 7.43 8.62
S&P BSE Healthcare -6.51 3.89 1.73 -17.89 -7.64 -1.43 12.44
Company's return has been calculated on basis of NSE's price.
As on Sep 20, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.94 3.30 -
Net Profit 26.99 5.79 -
EPS 26.99 5.79 -
Book Value 4.01 -0.67 -
Average
Operating Margin 22.48 19.64 20.98
Net Margin 13.79 12.36 12.59
Return on Networth 21.22 18.19 19.65
Return on Investment 32.54 27.83 30.37
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 4.90 7.12 4.90
Operating Profit -9.29 23.95 -9.29
Net Profit -7.78 28.07 -7.78
EPS -7.78 28.07 -7.78
TTM
Revenue 1.67 5.17 1.67
Operating Profit 5.35 8.61 5.35
Net Profit 5.85 8.71 5.85
EPS 5.85 8.71 5.85
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 23,466.97 3,180.90 450.23 13.66 21.22 10.40 52.12
Lupin 34,224.68 17,280.63 711.14 4.01 4.55 2.48 48.42
Torrent Pharmaceuticals 29,226.58 7,823.00 489.00 6.21 9.34 5.92 59.77
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 30, 2017 GlaxoSmithK Line Pte Ltd  Buy Off Market 3,192,238 2,731.45 87,194.38
Mar 30, 2017 GlaxoSmithKline Pte Ltd  Sell Off Market 3,192,238 2,731.45 87,194.38
Mar 10, 2014 Glaxosmithkline Pte Ltd.  Buy Off Market 20,609,774 2,508.80 517,058.01
Fund Houses invested in the stock
Fund Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
Aditya Birla Sun Life Mutual Fund 2.758 2.574 2.427 2.340 2.300
UTI Mutual Fund 0.128 0.128 0.128 0.128 0.138
L&T Mutual Fund 0.074 0.178 0.204 0.204 0.200
Mahindra Mutual Fund 0.022 0.022 0.013 - -
Reliance Mutual Fund 0.003 0.003 - 0.001 -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: [email protected]

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
3.58
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
51.76
5-Years Price to Book
10.33
Earnings Yield
EBIT / Enterprise value
3.18%
PEG
Price / Earnings to growth ratio
29.44
Related Stocks
  Current Price   Chng %
Abbott India R10,219.15 +3.88%
Alkem Laboratories R1,948.20 +4.36%
Biocon R228.05 +0.33%
Cadila Healthcare R247.45 +3.95%
Ipca Laboratories R956.10 +0.87%
Lupin R756.30 +2.03%
Pfizer R3,267.85 +0.72%
Sanofi India R5,890.20 +3.91%
Syngene International R317.80 +2.50%
Torrent Pharmaceuticals R1,727.20 +1.47%
As on Sep 20, 15:59